Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DOSAGE Study: a Multicenter Randomized Phase III Trial of DOSe-reduced Chemotherapy for Advanced Colorectal Cancer in Older Patients

NCT06275958 is registered in ClinicalTrials.gov with Leiden University Medical Center as lead sponsor.

NCT NCT06275958
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06275958 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DOSAGE Study: a Multicenter Randomized Phase III Trial of DOSe-reduced Chemotherapy for Advanced Colorectal Cancer in Older Patients
Lead sponsor
Leiden University Medical Center
Phase
Phase 3
Overall status
Recruiting
Start date
July 1, 2024
Completion date
December 31, 2028
Enrollment
587 (estimated)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

candidates for palliative chemotherapy, colorectal cancer, metastatic cancer, older patients